Prognostic markers in young patients with premature coronary heart disease

被引:45
作者
van Loon, Janine E. [1 ]
de Maat, Moniek P. M. [1 ]
Deckers, Jaap W. [2 ]
van Domburg, Ron T. [2 ]
Leebeek, Frank W. G. [1 ]
机构
[1] Erasmus Univ, Med Ctr, Dept Hematol, NL-3000 CA Rotterdam, Netherlands
[2] Erasmus Univ, Med Ctr, Dept Cardiol, NL-3000 CA Rotterdam, Netherlands
关键词
Premature coronary heart disease recurrent events; Prognosis; Risk factors; C-reactive protein; Von Willebrand factor; Fibrinogen; Prognostic markers; C-REACTIVE PROTEIN; ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; RISK; INFLAMMATION; MORTALITY; DEATH; ASSOCIATION; ADMISSION; ADULTS;
D O I
10.1016/j.atherosclerosis.2012.06.067
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To evaluate the survival and prognostic implications of cardiovascular, inflammatory and prothrombotic risk factors in young patients with premature coronary heart disease (CHD). Methods: Follow-up data were obtained from 353 young patients with a first cardiac event (men <= 45 years and women <= 55 years). Baseline characteristics on traditional risk factors were collected at the time of the first event, and plasma levels of C-reactive protein (CRP), von Willebrand Factor (VWF), and fibrinogen were measured one to three months after the first event to exclude an acute phase response. We performed age and sex adjusted Cox regression analyses to assess the relationship between these factors and recurrent events with three different endpoints: all cause mortality, recurrent cardiac event (myocardial infarction or revascularisation procedure), and any recurrent event (cardiac event, cerebrovascular event or all cause mortality). Results: During a total follow-up time of 1483 person years (mean 4.2 years), 11 patients died (3%), 42 patients had a recurrent cardiac event (12%), and 53 patients had any recurrent event (15%). CRP was associated with an increased risk of any recurrent event (HR 1.28[95% CI = 1.02-1.59] per unit increase in lnCRP). Also, both CRP (5.00[1.04-24.04]) and fibrinogen (5.04[1.05-24.23]) were associated with all cause mortality when levels were above the 50th percentile. Conclusions: Fifteen percent of young patients with a first cardiac event have a recurrent event or die within a median follow-up of 4.2 years. In these young patients we have shown that, independently of cardiovascular risk factors, high CRP levels contribute to the risk of recurrent events, including all cause mortality, and high fibrinogen levels are associated with all cause mortality. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:213 / 217
页数:5
相关论文
共 26 条
[1]   Myocardial infarction in young patients [J].
Choudhury, L ;
Marsh, JD .
AMERICAN JOURNAL OF MEDICINE, 1999, 107 (03) :254-261
[2]   COMPARISON OF THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION IN PATIENTS AGED LESS-THAN-35 AND GREATER-THAN-55 YEARS [J].
CHOUHAN, L ;
HAJAR, HA ;
POMPOSIELLO, JC .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (02) :157-159
[3]  
CLAUSS A., 1957, ACTA HAEMATOL, V17, P237
[4]   Long-term follow-up of coronary artery disease presenting in young adults [J].
Cole, JH ;
Miller, JI ;
Sperling, LS ;
Weintraub, WS .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (04) :521-528
[5]   Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality - An individual participant meta-analysis [J].
Danesh, J ;
Lewington, S ;
Thompson, SG ;
Lowe, GDO ;
Collins, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (14) :1799-1809
[6]   C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease [J].
Danesh, J ;
Wheeler, JG ;
Hirschfield, GM ;
Eda, S ;
Eiriksdottir, G ;
Rumley, A ;
Lowe, GDO ;
Pepys, MB ;
Gudnason, V .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (14) :1387-1397
[7]   The role of thrombin activatable fibrinolysis inhibitor in arterial thrombosis at a young age: the ATTAC study [J].
de Bruijne, E. L. E. ;
Gils, A. ;
Guimaraes, A. H. C. ;
Dippel, D. W. J. ;
Deckers, J. W. ;
van den Meiracker, A. H. ;
Poldermans, D. ;
Rijken, D. C. ;
Declerck, P. J. ;
de Maat, M. P. M. ;
Leebeek, F. W. G. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (06) :919-927
[8]   Innate immunity and coagulation [J].
Esmon, C. T. ;
Xu, J. ;
Lupu, F. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 :182-188
[9]   Association of C-reactive protein and serum amyloid A with recurrent coronary events in stable patients after healing of acute myocardial infarction [J].
Harb, TS ;
Zareba, W ;
Moss, AJ ;
Ridker, PM ;
Marder, VJ ;
Rifai, N ;
Watelet, LFM ;
Arora, R ;
Brown, MW ;
Case, RB ;
Dwyer, EM ;
Gillespie, JA ;
Goldstein, RE ;
Greenberg, H ;
Hochman, J ;
Krone, RJ ;
Liang, CS ;
Lichstein, E ;
Little, W ;
Marcus, FI ;
Oakes, D ;
Sparks, CE ;
VanVoorhees, L .
AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (02) :216-+
[10]   MYOCARDIAL-INFARCTION IN YOUNG-PATIENTS - AN ANALYSIS BY AGE SUBSETS [J].
HOIT, BD ;
GILPIN, EA ;
HENNING, H ;
MAISEL, AA ;
DITTRICH, H ;
CARLISLE, J ;
ROSS, J .
CIRCULATION, 1986, 74 (04) :712-721